Pathways and targets--opposite approaches to success?
作者信息
Blundy Keith
出版信息
Drug Discov Today. 2012 Mar;17(5-6):183-4. doi: 10.1016/j.drudis.2011.11.006. Epub 2011 Nov 26.
PMID:22138262
Abstract
摘要
相似文献
1
Pathways and targets--opposite approaches to success?途径与靶点——通往成功的相反路径？
Drug Discov Today. 2012 Mar;17(5-6):183-4. doi: 10.1016/j.drudis.2011.11.006. Epub 2011 Nov 26.
2
New avenues to target Wnt/β-catenin signaling.靶向 Wnt/β-catenin 信号通路的新途径。
Drug Discov Today. 2011 Jan;16(1-2):35-41. doi: 10.1016/j.drudis.2010.11.007. Epub 2010 Nov 24.
3
The future of neurodegenerative diseases: emerging targets, treatments and technologies.神经退行性疾病的未来：新兴靶点、治疗方法与技术
Future Med Chem. 2012 Sep;4(13):1661-9. doi: 10.4155/fmc.12.118.
4
Targeted drug development for arthritis.针对关节炎的靶向药物研发。
Future Med Chem. 2012 Apr;4(6):701-3. doi: 10.4155/fmc.12.24.
5
Multi-targeted hybrids based on HDAC inhibitors for anti-cancer drug discovery.基于组蛋白去乙酰化酶抑制剂的多靶点杂合化合物用于抗癌药物发现。
Arch Pharm Res. 2012 Feb;35(2):197-200. doi: 10.1007/s12272-012-0221-9.
6
Targeting survivin in cancer: the cell-signalling perspective.靶向生存素治疗癌症：细胞信号转导视角。
Drug Discov Today. 2011 Jun;16(11-12):485-94. doi: 10.1016/j.drudis.2011.04.001. Epub 2011 Apr 12.
7
Blocking the mTOR pathway: a drug discovery perspective.阻断 mTOR 通路：药物研发视角。
Biochem Soc Trans. 2011 Apr;39(2):451-5. doi: 10.1042/BST0390451.
8
Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance.纳米医学用于靶向癌症治疗：克服耐药性。
Drug Resist Updat. 2011 Jun;14(3):150-63. doi: 10.1016/j.drup.2011.01.003. Epub 2011 Feb 16.
9
Promising targets and drugs in development for colorectal cancer.结直肠癌的有前景的治疗靶点和在研药物。
Semin Oncol. 2011 Aug;38(4):588-97. doi: 10.1053/j.seminoncol.2011.05.013.
10
Q&A: Ashok Venkitaraman on "undruggable" targets. Interview by Eric Bender.问答：阿肖克·文基塔拉曼谈“难以成药”的靶点。埃里克·本德采访。
Cancer Discov. 2013 Jun;3(6):597. doi: 10.1158/2159-8290.CD-ND2013-014. Epub 2013 May 30.
Zotero 插件